This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Sarah Lovelock, Ph.D.
Reader in Biological Chemistry at University of Manchester


Dr Sarah L. Lovelock is an Associate Professor in Biological Chemistry at the University of Manchester. Sarah received her PhD from the University of Manchester where she worked under the supervision of Prof. Nicholas Turner. Following her PhD, she moved to GSK where she worked in the Advanced Manufacturing Technologies team, engineering enzymes for use in pharmaceutical manufacturing processes. She later returned to academia and in 2020 was awarded a UKRI Future Leader Fellowship. Sarah leads a multidisciplinary research team that specializes in engineering enzymes for application in sustainable pharmaceutical manufacturing, with a specific focus on developing biocatalytic approaches to therapeutic oligonucleotides.

Agenda Sessions

  • Biocatalytic Approaches to Nucleic Acid Therapeutics Manufacturing